Background
The relation between weight fluctuation and the risk of cardiovascular disease (CVD) is fairly consistent, although the physiologic basis for the relationship is uncertain. In the present study the association between long-term weight fluctuation and the development of metabolic syndrome (MS), a potent CVD risk factor, was investigated. Methods and Results A cross-sectional study of 664 Japanese men aged 40-49 years was conducted. The root mean square error around the slope of weight on age (weight -RMSE) was calculated by a simple linear regression model, in which the subject's actual weights at ages 20, 25, 30 years and 5 years prior to the study, as well as current weight, were dependent variables against the subject's age as the independent variable. Weight-RMSE was significantly and positively associated with the prevalence of each MS components (high blood pressure, hypertriglyceridemia, low-high density lipoprotein-cholesterol, high fasting glucose, and obesity). Such associations, as well as clustering of the MS component together with RMSE increase, were apparent among subjects with body mass index (BMI) <25 kg/m 2 , although the prevalence of MS or its components was much higher among overweight subjects (BMI ≥25 kg/m 2 ). ing status, drinking status, and physical activity. They underwent a physical examination including height, weight, and BP measured while seated after 5 min rest, and consented to collection of fasting blood samples.
Conclusions
For the present study, we obtained the subjects' actual weights at ages 20, 25, 30 years, and 5 years prior (in 1992) from the respective health checkup records. A complete data set was not available for 113 men. Seven men had a medical history of either cancer (5) or myocardial infarction (MI, 2) and they were excluded from the analyses, leaving 644 men. There was no difference between these 644 men and the 120 excluded men with regard to characteristics such as current body mass index (BMI), smoking status, and the characteristics of MS, except for a lower mean age in the excluded men.
Informed consent for the use of personal information for analysis was given by the population of this study. The study protocol was approved by the Ethics Committee of Nagoya University Graduate School of Medicine, Nagoya, Japan.
Body Size and Weight Variability Indices
Weight and height were measured in the morning in the fasting state to the nearest 0.1 kg and 0.1 cm, respectively, with subjects wearing light clothing and no shoes at all 5 time points. BMI was calculated as weight in kilograms divided by the square of height in meters and used as an index for obesity. Similar to our previous study, 14 weight variability was divided into 2 distinct components, that is, trend over time and fluctuation over time, using a simple linear regression model in which each value of the subject's actual weights at ages 20, 25, 30 years, 5 years ago, and present age were the 5 dependent variables and the subject's age at each examination the independent variables. The slope coefficient of this model was used as an index representing the trend of an individual's weight changes in terms of direction and magnitude (weight -slope), and the root mean square error (RMSE) of this model, a standard deviation around this slope, was used to represent the magnitude of weight fluctuation (weight -RMSE). Weight -slope was treated as the factor confounding the relationship between weight fluctuation and MS in this analysis.
Biochemical Analysis and Metabolic Syndrome
Venous blood samples were drawn from the subjects after 8 h or overnight fasting. Triglycerides (TG) was determined enzymatically. high density lipoprotein-cholesterol (HDL-C) was measured by the phosphotungstate method. Glucose was enzymatically determined by the hexokinase method.
The characteristics of MS components, except for obesity, were defined by the following cutoff values or conditions as detailed in the ATPIII report: High BP: sys- tolic BP ≥130 mmHg or diastolic BP ≥85 mmHg or under treatment; hypertriglyceridemia: TG ≥150 mg/dl or under treatment; low-HDL-C: HDL-C <40 mg/dl or under treatment; high fasting glucose: glucose ≥110 mg/dl or under treatment. As for obesity, the criteria of BMI ≥25 kg/m 2 was tentatively used instead of waist circumference according to the criteria recommended by the Japan Society for the Study of Obesity 15 because we could not obtain the latter.
In the present study, subjects having 3 or more of the aforementioned 5 components were regarded as having MS consistent with the ATPIII definition.
Statistical Analysis
A binary logistic regression model was used to assess the relationship between weight fluctuation during the period from age 20 to 1997 and MS. The subjects were divided into 2 dichotomous categories based on the criteria of each MS component. The outcome variable was defined as high BP, elevated TG, low HDL-C, high fasting glucose, and obesity. Each of them was compared with the respective normal groups. Weight fluctuation (weight -RMSE) was divided into quartiles. For each component of MS, odds ratios (OR) and the 95% confidence intervals (CI) according to the quartiles of weight -RMSE were calculated by treating the subjects in the lowest quartiles of weight -RMSE as the reference groups. A test for linear trend was performed on the continuous variables.
Adjustments were made for potential confounders, including age in Model 1. In addition, current BMI, BMI at 20 years, weight -slope, smoking status (never, exsmokers, and current smokers), alcohol consumption (the number of alcohol drinking days per week) and physical activity status (the frequency of exercise: none, 1-3 days per month, 1-2 days per week, ≥3 days per week) were contained in Model 2. Smoking and physical activity were treated as a categorical variable and the others as a continuous variable (Model 2). In examining the association between obesity and weight fluctuation, however, age, BMI at 20 years, smoking status, alcohol consumption, and physical activity status, but not current BMI, were adjusted (Model 3). Furthermore, the OR of the MS were calculated according to the quartiles of weight -RMSE. To elucidate the difference and similarity of the effects of weight -RMSE according to BMI categories, subjects were stratified into 2 subgroups by BMI 25 kg/m 2 . Here the quartile of 
Results
The characteristics of the 644 Japanese men by the quartile of weight -RMSE are shown in Table 1 . Current BMI, BMI at age 20, and the weight change slope showed a significantly increasing trend together with the increase of weight -RMSE. No significant difference in age was observed among the groups.
For all subjects, the prevalence and adjusted OR for each component of MS by the quartile of weight-RMSE are shown in Table 2 . The prevalence of each MS component was likely to increase with increasing weight -RMSE. The age-adjusted OR for high BP were 1.79 (95% CI: 1.12-2.88), 2.15 (95% CI: 1.34-3.45) and 2.04 (95% CI: 1.27-3.26) among subjects in the second, third and highest quartiles of weight -RMSE, respectively, compared with the lowest quartile of weight -RMSE (Model 1) (p value for trend =0.003). The OR for hypertriglyceridemia, low HDL-C, high fasting glucose, and obesity also showed increasing trends (hypertriglyceridemia: 1.00, 1.16, 2.33, and 2.39; low HDL-C: 1.00, 1.54, 2.36, and 2.25; high fasting glucose: 1.00, 1.34, 1.56, and 4.14; obesity: 1.00, 1.44, 1.55, and 3.27). On further adjustment for current BMI, BMI at 20 years, weight-slope, smoking, alcohol consumption, and physical activity, these OR were attenuated (Model 2), but the OR for hypertriglyceridemia and high fasting glucose remained significant and showed significantly increasing trends (hypertriglyceridemia: 1.00, 0.96, 1.88, and 1.60; high fasting glucose: 1.00, 1.22, 1.30, and 2.71). The strongest association was observed with high fasting glucose. Obesity also showed a strong association after an additional adjustment for multiple factors except for current BMI and weight -slope. Table 3 shows adjusted OR for each component of MS by quartiles of weight -RMSE, stratified by current BMI 25 kg/m 2 . The prevalence of each component was much higher among subjects with BMI ≥25 kg/m 2 than among those with BMI <25 kg/m 2 . However, the association between weight -RMSE and the prevalence of each component disappeared among subjects with BMI ≥25 kg/m 2 , whereas among subjects with BMI <25 kg/m 2 , higher multivariate OR for each component increased across quartiles of weight -RMSE.
Adjusted OR for the presence of MS defined by ATPIII are shown in Table 4 . When data were dichotomized at BMI 25 kg/m 2 , the linear trends in the OR for presence of MS (3 or more MS components) according to weight -RMSE quartile were statistically significant only among subjects with BMI <25 kg/m 2 . Among subjects with BMI ≥25 kg/m 2 , the prevalence of a state of MS (2 or more MS components besides obesity) was higher than that among those with BMI <25 kg/m 2 , but there was no association between weight -RMSE and a state of MS.
Discussion
To the best of our knowledge, this is the first populationbased study that reports the effect of long-term weight fluctuation on MS as defined in ATPIII, though slightly modified. Moreover, we calculated the weight fluctuation using actual measurements of body weight, whereas most of the previous studies 17 concerning the effects of longitudinal weight changes have used self-reported body weight in questionnaires and were not free from information bias.
The results of our study have several implications. First, we found that weight fluctuation was related to MS components independent of age, current and age 20 BMI, weight gain or loss (weight -slope), smoking, alcohol consumption, and physical activity. Several epidemiological studies 18, 19 have reported an association between weight fluctuation and chronic disease, or CVD. In the Baltimore Longitudinal Study, Lissner et al 18 found that a large weight fluctuation was associated with impaired glucose tolerance, and in the Iowa Women's Health Study, French et al 19 observed that weight fluctuation was associated with a higher risk of developing diseases such as MI and diabetes. However, there was no correlation in the Stanford Five-City Project between RMSE assessed on the basis of retrospective report of weights at 5-year intervals and the change in BP and cholesterol. 20 These results are in part consistent with the firm association of weight -RMSE with high fasting glucose and no association with hypertension in our study. A relationship between weight fluctuation and mortality from CVD is fairly consistent. [6] [7] [8] The physiological basis for this effect is uncertain, although it has been suggested that weight fluctuation may accelerate atherogenesis. Our previous study reported a positive association of weight fluctuation with fasting insulin concentration. 9 Taken together with the present results, weight fluctuation may cause MS on the basis of IR, and MS may give rise to CVD through atherogenesis.
To corroborate the hypothesis that weight fluctuation causes MS through IR, we need to further substantiate the pathophysiologic mechanism linking weight fluctuation and IR. It is possible that the development of MS that derives from IR may reflect an accumulation of adiposity, although we did not obtain the degree of total or abdominal adiposity or waist circumference. An experimental study 21 in rats reported a significant increase in visceral fat mass, which was related to IR, as a long-term consequence of weight cycling. Two studies in humans found a positive association of weight fluctuation with waist -hip ratio 22 or truncal adiposity. 18 Interestingly, when our data were dichotomized at BMI 25 kg/m 2 , the association between weight fluctuation and MS or each component of MS was pronounced only among subjects with BMI <25 kg/m 2 , which is consistent with other studies 9, 14, 23 in which adverse effects of weight change on health were seen more often among those who were not overweight, than among those who were overweight. The weight -RMSE value may reflect the degree of total or abdominal adiposity more exactly among normal-weight subjects than among obese ones. In other words, weight fluctuation may cause the amount of adiposity to increase among normal-weight subjects. On the basis of this connection, we examined the characteristics of normal-weight persons (BMI <25 kg/m 2 ) having a large weight fluctuation and found that the weight -slope increased as the weight -RMSE increased (weight-slope for Q1: 0.18, Q2: 0.23, Q3: 0.27, Q4: 0.27). The proportion of the subjects whose weight -slope was negative, that is, those who had a decreasing trend of weight, was 18.5% (23/124), 12.1% (12/124), 7.3% (9/115), and 10.5% (13/124) in Q1, Q2, Q3, and Q4, respectively. Most normal-weight persons with a large fluctuation had an increasing trend of weight although some of them were considered to be persons who had been obese in the past and currently were normal weight (in 1997). These findings suggest the significance of accumulation of adiposity in adulthood, even among the non-obese people, is the genesis of MS.
On the other hand, there was no association between weight -RMSE and the state of MS or each component of MS in those with BMI ≥25 kg/m 2 , although the prevalences of the MS components were much higher among overweight subjects than among those with normal weight. In our study, obese subjects had a high weight -RMSE. These facts suggest that high weight fluctuation related to high BMI may not necessarily be proportional to the amount of visceral fat among obese persons. Further studies together with measurements of adiposity are needed.
One of the strengths of the present study was our use of weight fluctuation over a longer period than any other published study. Moreover, weight fluctuation was calculated by means of measured weight, as opposed to selfreported body weight. Associations of disease with weight using self-reported measures are known to result in underestimation because overweight individuals tend to underreport and underweight individuals tend to overreport. However, several limitations of this study also deserve mention. First, our study lacked information as to reasons for the weight changes. We were unable to distinguish intentional from unintentional weight loss. Second, the present study cannot exclude the possibility that the MS components are the cause rather than the consequence of weight fluctuation. Third, participants were a series of workers who had been in a company from approximately the age of 20, and had been able to keep working until the year 1997. We excluded those with a history of medically treated MI or cancer, but there may have been a group of individuals with large weight fluctuation that had dropped out before the baseline. Thus, the present results may apply only to a relatively healthy population. Fourth, although waist circumference was used as the indicator for abdominal obesity in ATPIII, it was not available in our study. The criteria for obesity in ATPIII may not be suitable for Japanese who are leaner than their Western counterparts. From a study of 1,193 Japanese men, the Japan Society for the Study of Obesity reported that the correlation coefficients of BMI with visceral fat measured by CT were similar when BMI was replaced with waist circumference. 15 We, therefore, concluded that the obesity standard of BMI ≥25 kg/m 2 determined by the Japan Society for the Study of Obesity reflects well the abdominal obesity in Japanese. In the interpretation of our results, however, it is necessary to consider that the criteria of the MS in the present study are somewhat biased because neither waist circumference nor visceral fat area was measured by CT scan. Finally, the subjects in this study comprised middle-aged Japanese men, and thus the results may not apply to women or occidentals with a high BMI.
From this cross-sectional analysis of middle-aged Japanese men, we found a positive association between their current state of MS components and weight fluctuation that started from young adulthood, especially among normal-weight men. Furthermore, weight fluctuation was related to a clustering of MS components. Because MS components are considered to be the predictors of CVD, it is suggested that not only avoiding weight gain, but also maintaining a stable weight even in the normal-weight range from adolescence may help to prevent CVD. To further explore the effect of weight fluctuation on MS, it is necessary to conduct a prospectively designed study together with measurements of adiposity.
